相关实验视频
Updated: Jul 5, 2026

10:36
A Swine Model of Neonatal Asphyxia
Published on: October 11, 2011
14.3K
预防VAP使用高压盐水雾化在NICU:一个随机控制试验
Arpit Gupta1, Mukesh Vir Singh1, Rajesh Kumar Yadav1
1Department of Pediatrics, MLN Medical College, Prayagraj, Uttar Pradesh, India.
Indian pediatrics
|February 6, 2025
概括
高血压盐水雾化显著降低了新生儿的呼吸器相关肺炎 (VAP). 这项干预措施降低了VAP率,并修改了临床肺部感染评分 (mCPIS),但没有产生重大副作用.
科学领域:
- 新生儿重症监护服务新生儿重症监护服务
- 呼吸系统药物 呼吸系统药物
- 预防传染病 预防传染病
背景情况:
- 呼吸机相关肺炎 (VAP) 是需要机械通风的新生儿的一个重大问题.
- 减少VAP发病率的有效策略对于改善重症新生儿的治疗结果至关重要.
研究的目的:
- 评估雾化高盐水 (HS) 在机械通风新生儿中预防VAP的有效性和安全性.
- 为了比较接受HS雾化和没有接受HS雾化的新生儿之间的修改后的临床肺感染得分 (mCPIS).
主要方法:
- 一项随机对照试验在印度高等医疗中心进行,每组有143名新生儿.
- 干预组接受了七天的HS雾化或直到输出管.
- VAP发生率和mCPIS是主要结局措施,VAP通过阳性血液培养和临床特征得到证实.
主要成果:
- HS雾化导致VAP率降低33.52% (36.72与每1000通风日51.51相比;P=0.031).
- 在HS组中,mCPIS的平均值明显较低 (5.22对5.94;P=0.030).
- 在HS组中,只有5.5%的新生儿出现了喘息,这表明安全性很好.
结论:
- 用高血压盐水进行雾化是一种有效的方法,可以降低呼吸器新生儿的VAP发生率.
- 治疗耐受性良好,呼吸喘等副作用最小.
相关概念视频
Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Suctioning the Nasopharyngeal Airway
Nasopharyngeal suctioning is a procedure to remove secretions from the upper part of the respiratory tract that the patient cannot clear independently. It helps maintain airway patency and prevents complications such as aspiration pneumonia.
Equipment Required
Equipment Required
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation (NIPPV)
Noninvasive Positive-Pressure Ventilation (NIPPV)
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

